Vitalhub Corp.
Vitalhub Corp. (VHI.TO) Financial Performance & Income Statement Overview
Analyze Vitalhub Corp. (VHI.TO) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Vitalhub Corp. (VHI.TO) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Vitalhub Corp. VHI.TO financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $21.67M | $20.59M | $16.51M | $16.24M |
| Cost of Revenue | $4.23M | $3.84M | $3.22M | $3.07M |
| Gross Profit | $17.44M | $14.78M | $13.29M | $13.17M |
| Gross Profit Ratio | $0.80 | $0.72 | $0.81 | $0.81 |
| R&D Expenses | $5.22M | $4.19M | $3.94M | $3.68M |
| SG&A Expenses | $8.07M | $7.81M | $5.75M | $5.76M |
| Operating Expenses | $15.47M | $13.97M | $9.70M | $9.43M |
| Total Costs & Expenses | $19.70M | $17.81M | $14.31M | $13.81M |
| Interest Income | $535309.00 | $270367.00 | $766046.00 | $729595.00 |
| Interest Expense | $14903.00 | $8210.00 | $9277.00 | $11724.00 |
| Depreciation & Amortization | $2.18M | $1.96M | $1.40M | $1.31M |
| EBITDA | $3.69M | $2.15M | $3.77M | $2.70M |
| EBITDA Ratio | $0.17 | $0.10 | $0.23 | $0.17 |
| Operating Income | $1.98M | $2.78M | $2.19M | $2.43M |
| Operating Income Ratio | $0.09 | $0.14 | $0.13 | $0.15 |
| Other Income/Expenses (Net) | -$488169.00 | -$2.61M | $165841.00 | -$1.04M |
| Income Before Tax | $1.49M | $173000.00 | $2.36M | $1.38M |
| Income Before Tax Ratio | $0.07 | $0.008 | $0.14 | $0.09 |
| Income Tax Expense | $325941.00 | -$614244.00 | $1.13M | $1.72M |
| Net Income | $1.16M | $787244.00 | $1.23M | -$335053.00 |
| Net Income Ratio | $0.05 | $0.04 | $0.07 | -$0.02 |
| EPS | $0.02 | $0.02 | $0.02 | -$0.007 |
| Diluted EPS | $0.02 | $0.02 | $0.02 | -$0.007 |
| Weighted Avg Shares Outstanding | $55.47M | $49.20M | $50.88M | $49.97M |
| Weighted Avg Shares Outstanding (Diluted) | $57.61M | $49.20M | $52.27M | $49.97M |
Financial performance has remained strong, with revenue growing from $16.24M in Q2 2024 to $21.67M in Q1 2025. Gross profit continued to perform well, with margins at 80% in the latest quarter. Operating income reached $1.98M in Q1 2025, holding a steady 9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $3.69M. Net income rose to $1.16M, keeping EPS at $0.02. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan